Literature DB >> 19572993

Mechanisms underlying acquired von Willebrand syndrome associated with an IgM paraprotein.

M Mayerhofer1, A Haushofer, P A Kyrle, A Chott, C Müllner, P Quehenberger, N Worel, L Traby, S Eichinger.   

Abstract

Acquired von Willebrand (vW) syndrome is a rare bleeding disorder which is frequently associated with immunological, malignant or cardiovascular disorders. The underlying pathomechanisms, particularly in patients with IgM monoclonal gammopathies, often remain unknown. We report a patient with indolent small B-cell lymphoma (immunocytoma) and plasmacytic differentiation with an IgM kappa paraprotein who was admitted with retroperitoneal haematoma. Medical history and coagulation testing were consistent with acquired vW syndrome. vW immunohistochemistry showed normal cytoplasmic labelling of endothelial cells and megakaryocytes, whereas the lymphomatous infiltrate was negative. Acquired vW syndrome due to adsorption of vW factor on malignant cells was thus excluded. In the multimeric analysis, all multimers were present similar to that in type 1 vW syndrome, but the triplet structures were blurred. The bands on serum immunofixation electrophoresis were also atypically broadened, which suggested complex formation between the IgM and vW factor. Immunoprecipitation studies showed that the 176-kDa proteolytic fragment of vW factor co-precipitated with the IgM paraprotein in the patient but not in the controls, suggesting a specific interaction between vW factor and the paraprotein in the patient. The patient required surgery and was successfully managed by chemotherapy consisting of rituximab and fludarabin as well as plasma exchange.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572993     DOI: 10.1111/j.1365-2362.2009.02177.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

Review 1.  Immunoglobulin M Monoclonal Gammopathies of Clinical Significance.

Authors:  Louis-Pierre Girard; Cinnie Yentia Soekojo; Melissa Ooi; Wee Joo Chng; Sanjay de Mel
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

2.  Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy : Breaking a dangerous bond.

Authors:  Georg Jeryczynski; Hermine Agis; Sabine Eichinger-Hasenauer; Maria Theresa Krauth
Journal:  Wien Klin Wochenschr       Date:  2022-03-19       Impact factor: 2.275

3.  Splenic Marginal Zone Lymphoma with Acquired von Willebrand Syndrome Diagnosed via Splenic Bleeding.

Authors:  Yukiko Komeno; Naoki Shibuya; Hideki Uryu; Haruki Yamada; Takeo Toda; Masayuki Shibasaki; Shinji Kunishima; Kuniko Iihara; Tomiko Ryu
Journal:  Intern Med       Date:  2017-03-01       Impact factor: 1.271

4.  Good Profile of Efficacy/Tolerance of Bortezomib or Idelalisib in Waldenström Macroglobulinemia Associated with Acquired Von Willebrand Syndrome.

Authors:  Mario Ojeda-Uribe; Valérie Rimelen; Cathérine Marzullo
Journal:  J Blood Med       Date:  2020-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.